Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ECOR electroCore
0.371+0.001+0.27%
Close
02/03 16:00 ET
0.380+0.009+2.45%
Post Mkt Price 02/03 16:45 ET
High
0.390
Open
0.390
Turnover
59.11K
Low
0.370
Pre Close
0.370
Volume
154.01K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersAxcella Health (NASDAQ:AXLA) shares rose 64.0% to $0.71 during Tuesday's pre-market session. The market value of their outstanding shares is at $51.8 million. Baudax Bio (NASDAQ:BXRX) stock inc
ElectroCore, Inc. (NASDAQ:ECOR) Sees Large Decline in Short Interest
electroCore, Inc. (NASDAQ:ECOR – Get Rating) was the target of a significant decrease in short interest in December. As of December 30th, there was short interest totalling 771,000 shares, a decreas
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Celyad Oncology SA (NASDAQ:CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program CYAD-21
ElectroCore Rises 10% on Guiding Record Revenue for Q4
ElectroCore Sees Q4 Sales ~$2.5M Vs. $2.17M Est., Sees FY22 Sales ~$8.5M Vs. $8.2M Est.
electroCore Sees Q4 sales ~$2.5M Vs. $2.17M Est., Sees FY22 Sales ~$8.5M Vs. $8.2M Est.
ElectroCore Sees 2022 Rev $8.5M >ECOR
ElectroCore Sees 1Q Rev $2.5M >ECOR
ElectroCore Sees 1Q Rev $2.5M >ECOR
ElectroCore, Inc. (NASDAQ:ECOR) to Post Q4 2022 Earnings of ($0.07) Per Share, Brookline Capital Management Forecasts
electroCore, Inc. (NASDAQ:ECOR – Get Rating) – Equities researchers at Brookline Capital Management issued their Q4 2022 EPS estimates for shares of electroCore in a note issued to investors on Th
ElectroCore (NASDAQ:ECOR) Now Covered by Brookline Capital Acquisition
Equities researchers at Brookline Capital Acquisition began coverage on shares of electroCore (NASDAQ:ECOR – Get Rating) in a report issued on Friday, Benzinga reports. The firm set a "buy" rating on
Benzinga's Top Ratings Upgrades, Downgrades For January 13, 2023
UpgradesFor OrganiGram Holdings Inc (NASDAQ:OGI), Stifel upgraded the previous rating of Hold to Buy. In the first quarter, OrganiGram Holdings showed an EPS of $0.01, compared to $0.00 from the year-
Company Overview
More
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.
CEO： Mr. Daniel S. Goldberger
Market： NASDAQ
Listing Date： 06/22/2018
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet